• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Latin America's embrace of an unproven COVID treatment is hindering drug trials.

作者信息

Mega Emiliano Rodríguez

出版信息

Nature. 2020 Oct;586(7830):481-482. doi: 10.1038/d41586-020-02958-2.

DOI:10.1038/d41586-020-02958-2
PMID:33077974
Abstract
摘要

相似文献

1
Latin America's embrace of an unproven COVID treatment is hindering drug trials.拉丁美洲对一种未经证实的新冠治疗方法的接受正在阻碍药物试验。
Nature. 2020 Oct;586(7830):481-482. doi: 10.1038/d41586-020-02958-2.
2
Latin American scientific research prorities for COVID-19 prevention and control.拉丁美洲新冠疫情防控的科研重点
Biomedica. 2020 Oct 30;40(Supl. 2):9-13.
3
COVID-19 in Latin America.拉丁美洲的2019冠状病毒病
Lancet Infect Dis. 2020 May;20(5):547-548. doi: 10.1016/S1473-3099(20)30303-0. Epub 2020 Apr 17.
4
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?羟氯喹啉和伊维菌素：用于新冠病毒化学预防和治疗的协同组合？
J Am Acad Dermatol. 2020 Jun;82(6):e221. doi: 10.1016/j.jaad.2020.04.017. Epub 2020 Apr 10.
5
Should the Holy Week 2020 be cancelled in Latin America due to the COVID-19 pandemic?由于新冠疫情，2020年拉丁美洲的圣周应该取消吗？
Travel Med Infect Dis. 2020 Jul-Aug;36:101633. doi: 10.1016/j.tmaid.2020.101633. Epub 2020 Mar 20.
6
Latin American scientists join the coronavirus vaccine race: 'No one's coming to rescue us'.拉丁美洲科学家加入新冠病毒疫苗竞赛：“没人会来拯救我们” 。
Nature. 2020 Jun;582(7813):470-471. doi: 10.1038/d41586-020-01756-0.
7
COVID-19: leaving no one behind in Latin America.新冠疫情：不让拉丁美洲任何人掉队。
Lancet. 2020 Oct 10;396(10257):1070. doi: 10.1016/S0140-6736(20)32073-0.
8
COVID-19: Small-Molecule Clinical Trials Landscape.新冠病毒病（COVID-19）：小分子药物临床试验全景
Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.
9
Consider pregnancy in COVID-19 therapeutic drug and vaccine trials.考虑在新冠治疗药物和疫苗试验中纳入孕妇。
Lancet. 2020 May 23;395(10237):e92. doi: 10.1016/S0140-6736(20)31029-1. Epub 2020 May 13.
10
Responding to Covid-19 - A Once-in-a-Century Pandemic?应对新冠疫情——一场百年一遇的大流行病？
N Engl J Med. 2020 Apr 30;382(18):1677-1679. doi: 10.1056/NEJMp2003762. Epub 2020 Feb 28.

引用本文的文献

1
COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose-That Was the Question.新冠疫情与三种药物的故事：是否进行药物再利用——这就是问题所在。
Viruses. 2025 Jun 23;17(7):881. doi: 10.3390/v17070881.
2
Exploring the linkage between health technology assessment and decision making during COVID-19 public health emergency in a developing country: analysis of processes and results.探讨发展中国家 COVID-19 公共卫生应急期间健康技术评估与决策之间的联系：过程与结果分析。
Int J Technol Assess Health Care. 2024 Nov 4;40(1):e42. doi: 10.1017/S0266462324000473.
3
How to fight fake papers: a review on important information sources and steps towards solution of the problem.

本文引用的文献

1
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19.关于将伊维菌素重新用于治疗新冠肺炎的药代动力学考量
Br J Clin Pharmacol. 2021 Mar;87(3):1589-1590. doi: 10.1111/bcp.14476. Epub 2020 Jul 17.
2
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
3
Serious Neurological Adverse Events after Ivermectin-Do They Occur beyond the Indication of Onchocerciasis?
如何打击假论文：重要信息来源及解决问题步骤综述。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9281-9294. doi: 10.1007/s00210-024-03272-8. Epub 2024 Jul 6.
4
[Asymmetries between national articulation and the autonomy of state governments in implementing health technologies to fight COVID-19 in Argentina].[阿根廷在实施抗击新冠疫情卫生技术方面国家政策与州政府自主权之间的不对称性]
Cad Saude Publica. 2024 Apr 29;40(4):e00117923. doi: 10.1590/0102-311XES117923. eCollection 2024.
5
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses.回归SARS-CoV-2生物化学的基础：微血管闭塞性聚糖结合决定其发病机制并为治疗反应提供依据。
Viruses. 2024 Apr 22;16(4):647. doi: 10.3390/v16040647.
6
Ivermectin for treatment of COVID-19: A systematic review and meta-analysis.伊维菌素用于治疗2019冠状病毒病：一项系统评价与荟萃分析。
Heliyon. 2024 Mar 11;10(6):e27647. doi: 10.1016/j.heliyon.2024.e27647. eCollection 2024 Mar 30.
7
You must be myths-taken: Examining belief in falsehoods during the COVID-19 health crisis.你一定是误解了：在 COVID-19 健康危机期间，审视对虚假信息的信仰。
PLoS One. 2024 Mar 5;19(3):e0294471. doi: 10.1371/journal.pone.0294471. eCollection 2024.
8
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.伊维菌素治疗社区成人 COVID-19（PRINCIPLE）：一项短期和长期结局的开放、随机、对照、适应性平台试验。
J Infect. 2024 Apr;88(4):106130. doi: 10.1016/j.jinf.2024.106130. Epub 2024 Feb 29.
9
Inefficacious drugs against covid-19: analysis of sales, tweets, and search engines.针对 COVID-19 的无效药物：销售、推文和搜索引擎分析。
Rev Saude Publica. 2024 Feb 26;58:06. doi: 10.11606/s1518-8787.2024058005413. eCollection 2024.
10
Factors associated with the use of medicines and self-medication during the COVID-19 pandemic in 12 Latin American countries.12个拉丁美洲国家在2019年冠状病毒病大流行期间与用药及自我药疗相关的因素
Heliyon. 2023 Nov 16;10(1):e22299. doi: 10.1016/j.heliyon.2023.e22299. eCollection 2024 Jan 15.
伊维菌素治疗后的严重神经系统不良事件是否超出了盘尾丝虫病的适应证范围？
Am J Trop Med Hyg. 2018 Feb;98(2):382-388. doi: 10.4269/ajtmh.17-0042. Epub 2017 Nov 30.